Fig 10. The ATR-CHK1-CDC25C-cyclin B1/CDK1 pathway is activated in B19V-infected CD36⁺ EPCs.

(A&B) CD36⁺ EPCs were infected with B19V or mock-infected. (C) CD36⁺ EPCs were treated with VE821 or DMSO at 3 h prior to B19V infection. After 48 h, cells were collected, lysed, and examined by Western blot analysis for the indicated proteins. β-actin was used as a loading control.